COVID-19 Research Paper Volume 13, Issue 8 pp 10833—10852

Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19

Risk of bias summary.

Figure 3. Risk of bias summary.